KYORIN Pharmaceutical Co., Ltd. (TYO:4569)
Japan · Delayed Price · Currency is JPY 1,080.00
+4.00 (0.37%)
Nov 13, 2026, 3:30 PM JST
KYORIN Pharmaceutical Market Cap
KYORIN Pharmaceutical has a market cap or net worth of 62.04 billion as of November 13, 2026. It is the 16,132nd most valuable company in the world and the 1,209th biggest in Japan. Its market cap has decreased by 22.59% in one year.
Market Cap
62.04B
Enterprise Value
61.97B
Revenue
125.02B
Global Rank
Country Rank
#1,209 Japan
PE Ratio
159.94
ChartMarket Cap Chart
Since March 10, 2006, KYORIN Pharmaceutical's market cap has increased from 18.24B to 62.04B, an increase of 240.06%. That is a compound annual growth rate of 6.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 62.04B | -29.74% |
| Dec 30, 2025 | 88.30B | 2.13% |
| Dec 30, 2024 | 86.46B | -15.45% |
| Dec 29, 2023 | 102.26B | 3.75% |
| Dec 30, 2022 | 98.56B | -6.82% |
| Dec 30, 2021 | 105.78B | -4.89% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sawai Group Holdings | 188.45B |
| Towa Pharmaceutical | 164.70B |
| Kissei Pharmaceutical | 162.15B |
| Kaken Pharmaceutical | 144.85B |
| Mochida Pharmaceutical | 117.84B |
| Zeria Pharmaceutical | 92.04B |
| ASKA Pharmaceutical Holdings | 61.45B |
| Fuji Pharma | 48.50B |